secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2025-05-21T23:59:59+00:00
Accession:  0001641172-25-011939
Event type: litigation
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis settles litigation for $750k payable starting Jan 2026; raises ~$1M from warrant exercises
--------------------------------------------------------------------------------

- Settles two lawsuits (Physicians' Litigation and Medical Practice Entities' Litigation) for $750,000 total, payable in 12 equal monthly installments beginning January 2026.
- Settlement includes mutual release of all claims among all parties, with no admission of liability.
- Received approximately $1M in proceeds from warrant exercises, issuing 430,580 common shares; Series B Preferred converted into 342,016 common shares.
- Shares were issued without restrictive legend under the company's effective S-3 registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000164117225011939/0001641172-25-011939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000164117225011939/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-011939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer